Meropenem Kalceks

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections including complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, and severe sepsis or septic shock in hospitalized patients.

GNH USA supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with established cold‑chain logistics and regulatory support for cross‑border procurement. Our network ensures timely delivery and product integrity across EU and global markets.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections by targeting the cell wall synthesis pathway.

- Complicated intra‑abdominal infections: effective bacterial eradication and clinical cure. - Complicated urinary tract infections: resolves infection and prevents progression. - Bacterial meningitis: achieves cerebrospinal fluid sterilization and reduces mortality. - Severe sepsis and septic shock: provides broad‑spectrum coverage to control systemic infection.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limited. - Rash: skin erythema or pruritus. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate medical attention. - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile‑associated colitis: severe diarrhea due to bacterial overgrowth. - Severe renal impairment: acute kidney injury requiring monitoring.

Precautions should be observed when administering Meropenem.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy history: avoid in patients with known hypersensitivity to carbapenems or other β‑lactam antibiotics. - Pregnancy: use only if the potential benefit justifies the potential risk, as safety data are limited. - Concomitant valproic acid: monitor for decreased valproate levels which may precipitate seizures. - Superinfection: monitor for overgrowth of non‑susceptible organisms such as fungi or resistant bacteria. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medicines.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate concentrations, increasing seizure risk. - Phenobarbital, phenytoin, carbamazepine: these enzyme inducers increase meropenem clearance, potentially reducing efficacy. - Aminoglycosides or vancomycin: combined use may increase nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte disturbances. - Probenecid: can reduce renal excretion of meropenem, altering plasma levels. - Warfarin: infection and antibiotic therapy may affect INR; monitor coagulation status.